玻尿素毒素A用于管理连续异质:影响治疗成功的因素
Journal of pediatric ophthalmology and strabismus
|February 19, 2025
概括
毒素A型注射在73.5%的患者中有效地重新治疗了连续的异质性. 这种安全而可行的选择改善了运动对齐,为这种情况提供了新的治疗途径.
科学领域:
- 眼科医生 眼科 眼科
- 神经学 神经学
- 眼 手术 整形外科
背景情况:
- 连续的外热性可能是具有挑战性的管理,往往需要重复干预.
- 毒素A型 (BoNT-A) 已成为各种眼部运动障碍的潜在治疗剂.
研究的目的:
- 为了评估BoNT-A注射的疗效和安全性,作为连续异质的再治疗.
- 确定与成功治疗结果相关的因素.
主要方法:
- 对34名连续使用BoNT-A治疗的异质性患者进行了回顾性审查.
- 在电肌学指导下,将5个单位的BoNT-A注入侧直肠肌.
- 成功被定义为注射后偏差在10镜二光 (PD) 之内.
主要成果:
- 最终的成功率达到了73.5%.
- 注射前平均偏差超过20 PD,注射后减少到大约10 PD.
- 早期的近距离偏差和注射后的融合潜力与治疗成功有关.
结论:
- 接种BoNT-A注射是一种安全有效的连续异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构性异构的再治疗选择.
- 这种微创手术方法为手术重新干预提供了有价值的替代方案.
- 进一步的研究可能会阐明最佳的患者选择和成功的预测因素.
更多相关视频
相关概念视频
Open Angle Glaucoma: Treatment
384
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
384
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
650
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
650
Accessory Structures of the Eye
1.4K
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
1.4K
Angle Closure Glaucoma: Treatment
430
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
430
Skeletal Muscle Relaxants: Therapeutic Uses
460
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
460
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K


